RXILIENT
Live / Allowed — Approved for publication (as of 09 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79439298
- Mark type
- Design + words
- Filed
- 19 Nov 2025
- Attorney of record
- Kassandra Rittmer
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for application to the skin for skin care and wounds; pharmaceutical preparations for health care for treatment and prevention of tumors, cancer, immune diseases, central nervous system diseases, eye diseases and conditions, and dermatological disorders; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceuticals for ophthalmological use; biochemicals preparations for pharmaceutical use for treatment and prevention of tumors, cancer, immune diseases, central nervous system diseases, eye diseases and conditions, and dermatological disorders; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment and prevention of eye diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; preparations for the treatment of eye diseases; anti-cancer pharmaceutical preparations; veterinary pharmaceutical preparations in the form of capsules for the treatment and prevention of tumors, cancer, immune diseases, central nervous system diseases, eye diseases and conditions, and dermatological disorders; chemical preparations for pharmaceutical purposes for treatment and prevention of tumors, cancer, immune diseases, central nervous system diseases, eye diseases and conditions, and dermatological disorders; chemicals for pharmaceutical use for treatment and prevention of tumors, cancer, immune diseases, central nervous system diseases, eye diseases and conditions, and dermatological disorders; diagnostic agents for pharmaceutical use; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; natural pharmaceutical preparations for treatment and prevention of tumors, cancer, immune diseases, central nervous system diseases, eye diseases and conditions, and dermatological disorders; chemical preparations for medical purposes for treatment and prevention of tumors, cancer, immune diseases, central nervous system diseases, eye diseases and conditions, and dermatological disorders; antibiotic dermatological products; antimicrobials for dermatologic use; barrier lotions for dermatological use; cortisone-based dermatological creams; creams for dermatological use; dermatologic preparations for medical purposes; dermatological pharmaceutical preparations; dermatological pharmaceutical products; external dermatological preparations; gels for dermatological use; hydrocortisone skin creams for dermatological use; injectable dermal fillers; medicated creams for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; pharmaceutical preparations for treating epidermal problems; pharmaceutical products for use in dermatology; skin patches for the transdermal delivery of pharmaceuticals for treatment and prevention of tumors, cancer, immune diseases, central nervous system diseases, eye diseases and conditions, and dermatological disorders; topical dermatological preparations for medical purposes; pharmaceutical moisturizers for skin and eyes; and diagnostic preparations for medical use.
Owner
Prosecution history
- 09 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jul 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 21 Jul 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jul 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jul 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Jul 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Jun 2026 — REFUSAL PROCESSED BY IB
- 20 May 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 20 May 2026 — REFUSAL PROCESSED BY MPU
- 01 Apr 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 31 Mar 2026 — NON-FINAL ACTION WRITTEN
- 25 Mar 2026 — ASSIGNED TO EXAMINER